Impact News +++ Western Digital Q4 Earnings Beat as Revenue Jumps 44% on Cloud Demand (Zacks) +++ WESTERN DIGITAL Aktie +3,40%

REGENERON Aktie

>REGENERON Aktienkurs

663.9 EUR -0.2% (TradegateBSX)

Ask: 664.8 EUR / 90 Stück

Bid: 662.8 EUR / 90 Stück

Tagesumsatz: 52 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

REGENERON Aktie über LYNX handeln

Intraday

1 Jahr

>REGENERON Performance

1 Woche: +9,6%

1 Monat: +17,2%

3 Monate: +10,9%

6 Monate: +2,7%

1 Jahr: +35,0%

laufendes Jahr: +0,5%

>REGENERON Aktie

Profil:

Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases across eye care, immunology, oncology, cardiovascular health, and inflammation. Its current portfolio in..
>Volltext..

Insiderhandel:

>REGENERON Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>REGENERON Peer Group

Gesundheit, Antikörper- Behandlung, Augenmedizin/ Sehhilfen, Rheuma- Behandlung, Medizinprodukte & -technik/ Implantate/ Wundpflege
>Alle Branchen..

>REGENERON Chart & Kurs - NASDAQ

>REGENERON News

05.08.26 - 19:45	Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock (Zacks)
	Regeneron (REGN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions....

05.08.26 - 16:15	REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky (PR Newswire)
	Ryan Crowe Regeneron securities defendant liability allegations focus on investor-facing statements about the Phase III Fianlimab-Libtayo Study before REGN shares declined $102.09 per share from the Class Period high. NEW YORK, Aug. 5, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies......

05.08.26 - 12:21	Megatrend Folger: Regeneron zündet den Kursturbo (Der Aktionaer)
	Regeneron hat mit seinen jüngsten Quartalszahlen die Erwartungen deutlich übertroffen. Dupixent, Eylea in der höheren Dosierung und Libtayo wachsen kräftig, während die Aktie ihre monatelange Schwächephase beendet. Nach dem charttechnischen Befreiungsschlag könnte nun die nächste Rally starten....

04.08.26 - 18:39	REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit (PR Newswire)
	SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Regeneron Pharmaceuticals (NASDAQ: REGN) that a securities class action lawsuit has been filed after its surprising revelations concerning a Phase 3 clinical trial of a therapy intended to......

04.08.26 - 16:24	The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 14, 2026 in Regeneron Pharmaceuticals, Inc. Lawsuit - REGN (PR Newswire)
	NEW YORK, Aug. 4, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead......

04.08.26 - 12:39	REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action for Investors (PR Newswire)
	A securities fraud class action lawsuit has been filed on behalf of Regeneron investors after its stock plummeted almost 10% because Regeneron allegedly misled investors regarding the success of its Phase III Fianlimab-Libtayo clinical trial. NEW YORK, Aug. 4, 2026 /PRNewswire/ -- Leading......

03.08.26 - 10:48	Regeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGN (PR Newswire)
	LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ: REGN) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated......

03.08.26 - 10:48	REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm (PR Newswire)
	LOS ANGELES, Aug. 3, 2026 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ: REGN) for violations of §§10(b) and 20(a) of the......

01.08.26 - 17:12	July healthcare recap: Regeneron, DexCom shine as Moderna, managed-care stocks retreat (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.07.26 - 20:36	Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial′s Protocol and Ultimate Failure - HBSS (PR Newswire)
	SAN FRANCISCO, July 31, 2026 /PRNewswire/ -- Regeneron Pharmaceuticals (NASDAQ: REGN) faces a securities class action lawsuit after its surprising revelations concerning a Phase 3 clinical trial of a therapy intended to treat patients with melanoma. The news that the trial failed drove......

31.07.26 - 13:06	Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation (GlobeNewswire EN)
	Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation...

31.07.26 - 03:12	Regeneron (REGN) Q2 2026 Earnings Call Transcript (Fool)
	Revenue surged 17% as Dupixent and EYLEA HD posted record sales....

30.07.26 - 20:30	Regeneron expects EYLEA HD demand growth in the low to mid-teens in Q3–Q4 2026 amid prefilled syringe push (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 18:15	Regeneron (REGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
	While the top- and bottom-line numbers for Regeneron (REGN) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values....

30.07.26 - 17:21	REGN Deadline Alert: SueWallSt Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026 (PR Newswire)
	Important Notice Regarding Alleged Phase III Fianlimab-Libtayo Clinical Trial Risk Misrepresentations. The lawsuit alleges Regeneron investors overpaid while the Company characterized slowing event accrual as potentially favorable, even as the study allegedly faced heightened risk of......

30.07.26 - 16:30	Regeneron Pharmaceuticals declares $0.94 dividend (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 14:12	Regeneron übertrifft Erwartungen deutlich: Aktie legt vorbörslich zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 13:24	Regeneron Pharmaceuticals Inc Bottom Line Retreats In Q2 (AFX)
	WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals Inc (REGN) revealed a profit for second quarter that Drops, from the same period last yearThe company's earnings totaled $1.296 billion, or $12.23 ......

30.07.26 - 13:18	Regeneron rises after strong Q2 beat powered by high-dose Eylea (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 12:39	Regeneron Pharmaceuticals beats top-line and bottom-line estimates; updates FY26 outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Philosophen verderben die Sprache, Poeten die Logik, und mit dem Menschenverstand kommt man durchs Leben nicht mehr. - Friedrich Johann Christoph Schiller

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram